Acquired array (CLL and MDS)
Chronic Lymphocytic Leukaemia (CLL) Myelodysplastic syndrome (MDS)
PURPOSE OF PROGRAMME:
Analysis and interpretation of recurrent and non-recurrent copy number changes in chronic lymphocytic leukaemia and myeloid disorders: DNA for array or NGS studies.
MATERIAL PROVIDED: DNA in TE buffer
DISTRIBUTIONS PER YEAR: 1
SAMPLES PER DISTRIBUTION: 2
FREQUENCY OF DISTRIBUTION: 1
PROGRAMME OF ANALYSIS:
Whole genome copy number changes and structural rearrangements.
Details of the performance criteria for this programme can be obtained from UK NEQAS Genomics (GenQA) directly.
Telephone: +44 (0) 131 2426898
From 1st January 2018, Cytogenomics External Quality Assessment Service (CEQAS) and UK National External Quality Assessment Service (UK NEQAS) for Molecular Genetics merged to become Genomics Quality Assessment (GenQA). Please click here for an overview of GenQA